Results

Total Results: 1,887 records

Showing results for "groups".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rotator-cuff-tears-future_research.pdf
    February 01, 2013 - Medline from September 2009 through August 2011 for RCTs and observational studies with comparison groups … Future clinical investigation should utilize comparison groups where possible. … 3 3 Which patient groups (for example, acute/chronic, older active/inactive, worker’s compensation … These studies compare one or more groups of individuals who have a risk factor or treatment to “control … Was nominated/strongly supported by one or more stakeholder groups 2d.
  2. effectivehealthcare.ahrq.gov/sites/default/files/cer-231-dementia-interventions-evidence-summary_0.pdf
    August 01, 2020 - Many important groups were rarely studied, including people with Down syndrome, who are living longer … Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
    September 11, 2015 - We also formed three categories for the comparator groups: usual care, active “non-DSME education” … KQ 6 focused on whether variability between population groups affected the role of potential factors … Sixty-four programs were delivered to individuals only, 56 were delivered to groups only, and 44 had … Participants, or their providers, in the usual care or active control groups (not being blinded to … Studies having clinically important effect sizes that offered programs in groups tended to be those
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias-individual-studies_methods.pdf
    March 01, 2012 - to, overlap with, or are distinct from risk-of-bias assessment of individual studies, some review groups … Attrition bias can potentially change the collective (group) characteristics of the relevant groups … Duration of follow-up is one such example: if duration of followup is different across comparison groups … x Were participants analyzed within the groups they were originally assigned to? … x x Did the study apply inclusion/exclusion criteria uniformly to all comparison groups?
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0174_10-20-2009.pdf
    January 01, 2009 - Topic Description Nominators: Two public payer groups Nomination Summary: The nominators
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0272_03-06-2008.pdf
    January 01, 2008 - association Nomination Summary: This topic represents nominations, respectively, by three nominating groups
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0576-150420.pdf
    December 10, 2014 -  An AHRQ product has the potential for impact because of high interest from potential stakeholder groups
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0012_03-21-2008.pdf
    January 01, 2008 - Does screening high-risk groups for sub-clinical thyroid dysfunction reduce morbidity or mortality?
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0024_06-09-2008.pdf
    January 01, 2008 - Are there subgroups of patients based on demographics (age, racial groups, gender), other medications
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
    January 01, 2020 - Because we found that no groups of studies were amenable to pooling with meta-analyses, we calculated … College groups to discuss healthy diets and physical activity also prevented weight gain. … Many control groups had no increase in weight over time. … Less intensive interventions may be possible given that control groups maintained weight comparable … with the intervention groups in most of the studies that we included.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
    September 01, 2017 - • Key Question 5: Are any of the medications more or less effective than other medications for sub- groups … • Key Question 5: Are any of the medications more or less effective than other medications for sub-groups … Smoking decreased more in the disulfiram group than naltrexone or acamprosate groups. 2.Unsure … The exception was alcohol withdrawal syndrome, which was more common in nalmefene than placebo groups … slightly Likely current Acamprosate Men vs women There was no significant difference between groups
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_executive.pdf
    December 01, 2014 - commonly used, has significant limitations in assessing patients in the intermediate- and high-risk groups … was not reported, a difference of 15 percent or less in the length of followup for the comparison groups … assessors, trial had a difference of 15 percent or more in the length of followup for comparison groups … BT, PCSM 3 studies35,39,42 (N = 22,337) Outcomes between groups did not differ significantly in … Atlanta: American Cancer Society; 2012. www.cancer.org/acs/groups/ content/@epidemiologysurveilance
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-executive-summary.pdf
    March 01, 2024 - Treatment • We found that several treatment modalities improve core ADHD symptoms compared to control groups … We found that several treatment modalities improve core ADHD symptoms compared to control groups (e.g
  14. effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
    April 09, 2020 - B Mask use ≥5 hours/day: 76% (56/75) vs. 12% (11/89) Open-label Baseline differences between groups No … Index case Both groups: Index patient encouraged to sleep alone 7 days Index cases A: 25 B: 28 Household … HCWs Both groups were expected to follow hospital guidelines on hand washing. … 5% vs. 7% Practiced good hand hygiene: 56% vs. 54% vs. 46% Open-label Baseline differences between groups … Control (n=67 in 28 households): No hand rub or face masks Index cases and household contacts Mask groups
  15. effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
    April 09, 2020 - B Mask use ≥5 hours/day: 76% (56/75) vs. 12% (11/89) Open-label Baseline differences between groups No … Index case Both groups: Index patient encouraged to sleep alone 7 days Index cases A: 25 B: 28 Household … HCWs Both groups were expected to follow hospital guidelines on hand washing. … 5% vs. 7% Practiced good hand hygiene: 56% vs. 54% vs. 46% Open-label Baseline differences between groups … Control (n=67 in 28 households): No hand rub or face masks Index cases and household contacts Mask groups
  16. effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
    April 09, 2020 - B Mask use ≥5 hours/day: 76% (56/75) vs. 12% (11/89) Open-label Baseline differences between groups No … Index case Both groups: Index patient encouraged to sleep alone 7 days Index cases A: 25 B: 28 Household … HCWs Both groups were expected to follow hospital guidelines on hand washing. … 5% vs. 7% Practiced good hand hygiene: 56% vs. 54% vs. 46% Open-label Baseline differences between groups … Control (n=67 in 28 households): No hand rub or face masks Index cases and household contacts Mask groups
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
    April 09, 2020 - B Mask use ≥5 hours/day: 76% (56/75) vs. 12% (11/89) Open-label Baseline differences between groups No … Index case Both groups: Index patient encouraged to sleep alone 7 days Index cases A: 25 B: 28 Household … HCWs Both groups were expected to follow hospital guidelines on hand washing. … 5% vs. 7% Practiced good hand hygiene: 56% vs. 54% vs. 46% Open-label Baseline differences between groups … Control (n=67 in 28 households): No hand rub or facemasks Index cases and household contacts Mask groups
  18. effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - The investigators reported that both treatment groups showed statistically significant improvements … Younger patients with less cartilage degeneration achieved better results in both groups. … At month 3, more patients given tofacitinib (59.8% and 65.7% in the 5 and 10 mg groups, respectively … (-0.50 and -0.57 points, respectively) than in the placebo groups (-0.19 points; p<0.001). 49 The … tofacitinib 5 or 10 mg twice daily groups did not achieve a significant reduction in the percentage
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-app-g1.xlsx
    January 01, 2022 - 1.3) Did baseline differences between intervention groups suggest a problem with the randomization process … If Y, PY, NI to previous question) were these deviations from intended intervention balanced between groups … 4.2) Could measurement or ascertainment of the outcome have differed between intervention groups?
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/bipolar-disorder-treatment_research-protocol.pdf
    June 23, 2014 - bipolar disorder, with relatively similar prevalence in men and women, and across cultural and ethnic groups … Comparator Pharmacologic treatment – placebo, active control groups Behavioral or Somatic treatment … Any attempt to balance the allocation between the groups (e.g. … (self-report, scales with lower validity, reliability); not equivalent across groups Uncertain Could … Is the length of follow-up the same for all groups?

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: